Skip to main content

Published locations for Outpatient lenalidomide/rituximab yields long-term MCL remission

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Outpatient lenalidomide/rituximab yields long-term MCL remission

User login

  • Reset your password
  • /content/outpatient-lenalidomide/rituximab-yields-long-term-mcl-remission
  • /hematologynews/article/175628/mantle-cell-lymphoma/outpatient-lenalidomide/rituximab-yields-long
  • /oncologypractice/article/175628/mantle-cell-lymphoma/outpatient-lenalidomide/rituximab-yields-long
  • /fedprac/avaho/article/175628/mantle-cell-lymphoma/outpatient-lenalidomide/rituximab-yields-long-term
  • /hematologynews/nhlhub/article/175628/mantle-cell-lymphoma/outpatient-lenalidomide/rituximab-yields
  • /hematology-oncology/article/175628/mantle-cell-lymphoma/outpatient-lenalidomide/rituximab-yields
  • /b-cell-lymphoma-icymi/article/175628/mantle-cell-lymphoma/outpatient-lenalidomide/rituximab-yields